The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Dementia Praecox and Paraphrenia.
(1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-6-1058_8 · Cited by 2,901
Research summary on the therapeutic relationship and psychotherapy outcome.
Lambert, M. J., & Barley, D. E. (2001) · Psychotherapy: Theory, Research, Practice, Training · doi:10.1037/0033-3204.38.4.357 · Cited by 1,621
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
Brines, M. L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N. C., Cerami, C., Itri, L. M., & Cerami, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10526 · Cited by 1,402
Identification of separable cognitive factors in schizophrenia
Nuechterlein, K. H., Barch, D. M., Gold, J. M., Goldberg, T. E., Green, M. F., & Heaton, R. K. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.007 · Cited by 1,304
Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data
Cnaan, A., Laird, N. M., & Slasor, P. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19971030)16:20<2349::aid-sim667>3.0.co;2-e · Cited by 1,222
Schizophrenia as a Disorder of Neurodevelopment
Lewis, D. A., & Levitt, P. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142754 · Cited by 1,163
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
Ehrenreich, H., Hasselblatt, M., Dembowski, C., Cepek, L., Lewczuk, P., Stiefel, M., Rustenbeck, H.-H., Breiter, N., Jacob, S., Knerlich, F., et al. (2002) · Molecular Medicine · doi:10.1007/bf03402029 · Cited by 1,028
Self-citationErythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
Sirén, A.-L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Gleiter, C., Pasquali, C., Capobianco, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051606598 · Cited by 1,019
Self-citationThe Positive and Negative Syndrome Scale (PANSS): rationale and standardisation
Kay, S. R., Opler, L. A., & Lindenmayer, J.-P. (1989) · British Journal of Psychiatry · doi:10.1192/s0007125000291514 · Cited by 1,016
Prabakaran, S., Swatton, J. E., Ryan, M. M., Huffaker, S. J., Huang, J.-J., Griffin, J. L., Wayland, M., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001511 · Cited by 971
In vivo evidence that erythropoietin protects neurons from ischemic damage
Sakanaka, M., Wen, T.-C., Matsuda, S., Masuda, S., Morishita, E., Nagao, M., & Sasaki, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4635 · Cited by 949
The S100 protein family: History, function, and expression
Zimmer, D. B., Cornwall, E. H., Landar, A., & Song, W. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(95)00040-2 · Cited by 927
Thompson, P. M., Vidal, C., Giedd, J. N., Gochman, P., Blumenthal, J., Nicolson, R., Toga, A. W., & Rapoport, J. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201243998 · Cited by 812
Derivatives of Erythropoietin That Are Tissue Protective But Not Erythropoietic
Leist, M., Ghezzi, P., Grasso, G., Bianchi, R., Villa, P., Fratelli, M., Savino, C., Bianchi, M., Nielsen, J., Gerwien, J., et al. (2004) · Science · doi:10.1126/science.1098313 · Cited by 803
Antipsychotic Drug Effects on Brain Morphology in First-Episode Psychosis
Lieberman, J. A. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.361 · Cited by 801
Mehrfachwahl-Wortschatz-Intelligenztest
Lehrl, S. (2005) · Cited by 729
Molecular Psychology: Roles for the ERK MAP Kinase Cascade in Memory
Adams, J. P., & Sweatt, J. D. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082701.145401 · Cited by 593
Longitudinal study of brain morphology in first episode schizophrenia
Lieberman, J., Chakos, M., Wu, H., Alvir, J., Hoffman, E., Robinson, D., & Bilder, R. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01067-8 · Cited by 554
Bilder, R. M., Goldman, R. S., Volavka, J., Czobor, P., Hoptman, M., Sheitman, B., Lindenmayer, J.-P., Citrome, L., McEvoy, J., Kunz, M., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.6.1018 · Cited by 538
Emerging biological roles for erythropoietin in the nervous system
Brines, M., & Cerami, A. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1687 · Cited by 523
Emerging principles of altered neural circuitry in schizophrenia
Benes, F. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00041-7 · Cited by 513
Is schizophrenia a neurodegenerative disorder? a clinical and neurobiological perspective
Lieberman, J. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00147-x · Cited by 483
Buchanan, R. W. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi020 · Cited by 438
Häfner, H., & an der Heiden, W. (1997) · The Canadian Journal of Psychiatry · doi:10.1177/070674379704200204 · Cited by 436
Brain Volume Changes in First-Episode Schizophrenia: A 1-Year Follow-up Study
Cahn, W., Pol, H. E. H., Lems, E. B. T. E., van Haren, N. E. M., Schnack, H. G., van der Linden, J. A., Schothorst, P. F., van Engeland, H., & Kahn, R. S. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.11.1002 · Cited by 400
Day, J. C., Bentall, R. P., Roberts, C., Randall, F., Rogers, A., Cattell, D., Healy, D., Rae, P., & Power, C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.7.717 · Cited by 360
Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain
Sirén, A.-L., Knerlich, F., Poser, W., Gleiter, C. H., Brück, W., & Ehrenreich, H. (2001) · Acta Neuropathologica · doi:10.1007/s004010000297 · Cited by 349
Self-citationImprovement of schizophrenic patients’ subjective well-being under atypical antipsychotic drugs
Naber, D., Moritz, S., Lambert, M., Rajonk, F., Holzbach, R., Mass, R., Andresen, B., Frank, P., Rüdiger, H., Reinhard, M., et al. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00166-3 · Cited by 348
Prevalence and Incidence Studies of Schizophrenic Disorders: A Systematic Review of the Literature
Goldner, E. M., Hsu, L., Waraich, P., & Somers, J. M. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700904 · Cited by 339
Anemia of inflammation: the cytokine-hepcidin link
Andrews, N. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21441 · Cited by 334
Haack, M., Hinze-Selch, D., Fenzel, T., Kraus, T., Kühn, M., Schuld, A., & Pollmächer, T. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00021-7 · Cited by 329
Self-citationSchizophrenia: the fundamental questions
Andreasen, N. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00027-2 · Cited by 312
Glial protein S100B modulates long-term neuronal synaptic plasticity
Nishiyama, H., Knöpfel, T., Endo, S., & Itohara, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052020999 · Cited by 288
Theories of schizophrenia: a genetic-inflammatory-vascular synthesis
Hanson, D. R., & Gottesman, I. I. (2005) · BMC Medical Genetics · doi:10.1186/1471-2350-6-7 · Cited by 276
Weinberger, D. R., & McClure, R. K. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.553 · Cited by 260
Hoff, A. L., Svetina, C., Shields, G., Stewart, J., & DeLisi, L. E. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.05.010 · Cited by 259
Harvey, P. D., Green, M. F., Keefe, R. S. E., & Velligan, D. I. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0312 · Cited by 215
Erythropoietin: a candidate compound for neuroprotection in schizophrenia
Ehrenreich, H., Degner, D., Meller, J., Brines, M., Béhé, M., Hasselblatt, M., Woldt, H., Falkai, P., Knerlich, F., Jacob, S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001442 · Cited by 208
Self-citationThe neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone
Green, M. F., Marder, S. R., Glynn, S. M., McGurk, S. R., Wirshing, W. C., Wirshing, D. A., Liberman, R. P., & Mintz, J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01370-7 · Cited by 202
Effects of Erythropoietin on Neuronal Activity
Koshimura, K., Murakami, Y., Sohmiya, M., Tanaka, J., & Kato, Y. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722565.x · Cited by 185
Hobart, M. P., Goldberg, R., Bartko, J. J., & Gold, J. M. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.12.1951 · Cited by 181
Dickerson, F., Boronow, J. J., Stallings, C., Origoni, A. E., Cole, S. K., & Yolken, R. H. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.07.002 · Cited by 180
Ganz, T. (2004) · Current Opinion in Hematology · doi:10.1097/00062752-200407000-00004 · Cited by 166
Schizophrenia: From Dopamine to Glutamate and Back
Carlsson, M., Carlsson, A., & Nilsson, M. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043456034 · Cited by 162
Erythropoietin protects the in vitro blood–brain barrier against VEGF‐induced permeability
Martínez‐Estrada, O. M., Rodríguez‐Millán, E., González‐de Vicente, E., Reina, M., Vilaró, S., & Fabre, M. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02987.x · Cited by 161
Cuesta, M. J., Peralta, V., & Zarzuela, A. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00112-2 · Cited by 158
Wilk, C. M., Gold, J. M., Humber, K., Dickerson, F., Fenton, W. S., & Buchanan, R. W. (2003) · Schizophrenia Research · doi:10.1016/j.schres.2003.10.009 · Cited by 132
Another view of therapy for cognition in schizophrenia
Carpenter, W. T., & Gold, J. M. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01399-9 · Cited by 127
Erythropoietin: Novel Approaches to Neuroprotection in Human Brain Disease
Ehrenreich, H., Aust, C., Krampe, H., Jahn, H., Jacob, S., Herrmann, M., & Sirén, A. (2004) · Metabolic Brain Disease · doi:10.1023/b:mebr.0000043969.96895.3c · Cited by 123
Self-citationS100B Serum Levels and Long-Term Improvement of Negative Symptoms in Patients with Schizophrenia
Rothermundt, M., Ponath, G. D., Gläser, T., Hetzel, G., & Arolt, V. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300403 · Cited by 118
Flashman, L. A., & Green, M. F. (2004) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00105-9 · Cited by 112
Identification of a neurotrophic sequence in erythropoietin.
Campana, W. M., Misasi, R., & O′Brien, J. S. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm.1.1.235 · Cited by 111
Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin
Sirén, A., Radyushkin, K., Boretius, S., Kämmer, D., Riechers, C.-C., Natt, O., Sargin, D., Watanabe, T., Sperling, S., Michaelis, T., et al. (2005) · Brain · doi:10.1093/brain/awh703 · Cited by 102
Self-citationNeurocognitive, social, and emotional dysfunction in deficit syndrome schizophrenia
Horan, W. P. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00410-3 · Cited by 98
Neuropsychology in schizophrenia: an update
Hoff, A. L., & Kremen, W. S. (2003) · Current Opinion in Psychiatry · doi:10.1097/00001504-200303000-00003 · Cited by 91
Serum S100B is increased during early treatment with antipsychotics and in deficit schizophrenia
Schroeter, M. L. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00383-3 · Cited by 82
Shields, J., & Gottesman, I. I. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750300005001 · Cited by 71
Tainted Glory — Doping and Athletic Performance
Noakes, T. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048208 · Cited by 68
Cognitive Factors in Schizophrenia: Causes, Impact, and Treatment
Meltzer, H. Y. (2004) · CNS Spectrums · doi:10.1017/s1092852900025098 · Cited by 57
Weber, A., Maier, R. F., Hoffmann, U., Grips, M., Hoppenz, M., Aktas, A. G., Heinemann, U., Obladen, M., & Schuchmann, S. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03604-1 · Cited by 54
Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.
Stip, É. (2000) · PubMed · Cited by 53
A Boost for Translational Neuroscience
Ehrenreich, H. (2004) · Science · doi:10.1126/science.1100891 · Cited by 24
Self-citationPharmakotherapie der Schizophrenie
Fleischhacker, W. W., & Hummer, M. (2006) · Der Nervenarzt · doi:10.1007/s00115-006-2194-8 · Cited by 16
6 Pharmakotherapie der Schizophrenie
(2004) · Thieme eBooks · doi:10.1055/b-0034-19705 · Cited by 11
Epidemiology of schizophrenia. A thriving discipline at the turn of the century
Häfner, H. (2000) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060070001 · Cited by 10
Cited by
Miyamoto, S., Miyake, N., Jarskog, L. F., Fleischhacker, W. W., & Lieberman, J. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.47 · Cited by 573
The non‐haematopoietic biological effects of erythropoietin
Arcasoy, M. O. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07014.x · Cited by 347
Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin
Brines, M., Patel, N. S. A., Villa, P., Brines, C., Mennini, T., De Paola, M., Erbayraktar, Z., Erbayraktar, S., Sepodes, B., Thiemermann, C., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805594105 · Cited by 319
Molecular Mechanisms of Schizophrenia
Lang, U. E., Puls, I., Müller, D. J., Strutz-Seebohm, N., & Gallinat, J. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000110430 · Cited by 281
Systematic review of the neural basis of social cognition in patients with mood disorders
Cusi, A. M., Nazarov, A., Holshausen, K., MacQueen, G. M., & McKinnon, M. C. (2012) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100179 · Cited by 278
Metadata
- Authors
- Ehrenreich, H., Hinze-Selch, D., Stawicki, S., Aust, C., Knolle-Veentjer, S., Wilms, S., Heinz, G., Erdag, S., Jahn, H., Degner, D., Ritzen, M., Mohr, A., Wagner, M., Schneider, U., Bohn, M., Huber, M., Czernik, A., Pollmächer, T., Maier, W., Sirén, A.-L., Klosterkötter, J., Falkai, P., Rüther, E., Aldenhoff, J. B., & Krampe, H.
- Venue
- Molecular Psychiatry
- Published
- 2006-10-10
- Volume
- 12
- Issue
- 2
- Pages
- 206-220
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2111144499
- Cited by
- 258
- References
- 66
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.